wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 251 - 300 of 313.

Chemistry - Physics/Materials Science
30.03.2017
Observing chemical reactions in real
Observing chemical reactions in real
At Empa's Electron Microscopy Center, a new transmission electron microscope has recently been used that offers completely new opportunities for the physical and chemical analysis of very small samples. It can be used, for example, to observe the growth of nanocrystals in real time - and to record it on video.
Event - Physics/Materials Science
30.03.2017
Spark Award for fundamental research
ETH Professor Sabine Werner and her team won the Spark Award 2017 yesterday for their groundbreaking new approach to combating viral diseases. If their results can be confirmed, they could lead to the development of better treatments for viral diseases such as herpes.
Medicine/Pharmacology
30.03.2017
Kidney Transplants: White Blood Cells Control Virus Replication
Kidney Transplants: White Blood Cells Control Virus Replication
Certain white blood cells play an important role in bringing a harmful virus under control after kidney transplantations. The results of a research group at the Department of Biomedicine at the University of Basel and University Hospital Basel could contribute to improving control of immunosuppression, avoiding transplant rejection and developing relevant vaccines.
Physics/Materials Science
29.03.2017
Federal Councillor Schneider-Ammann meets British Minister of State Jo Johnson
Bern, 29.03.2017 - On 29 March Federal Councillor Johann N. Schneider-Ammann, the head of the Federal Department of Economic Affairs, Education and Research (EAER), met his British counterpart, Jo Johnson, the Minister of State for Universities.
Medicine/Pharmacology - Life Sciences
29.03.2017
Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
Priority review for investigational CTL019 (tisagenlecleucel-T), a novel therapy that is manufactured for each individual patient using their own T'cells Novartis made an early commitment to the emer
Medicine/Pharmacology - Life Sciences
29.03.2017
FDA approves Roche‘s OCREVUS’ (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
FDA approves Roche‘s OCREVUS' (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis First and only approved disease-modifying therapy for primary progressive form of m
Physics/Materials Science - Business/Economics
28.03.2017
Dominique Derome new Head of Laboratory
Dominique Derome new Head of Laboratory
On 1 April 2017, Dominique Derome will become the new Head of the Laboratory for Multiscale Studies in Building Physics.
Earth Sciences - Business/Economics
27.03.2017
Archival photos offer research value
Archival photos offer research value
A crowdmapping project developed by EPFL and HEIG-VD gives volunteers the chance to compare the Switzerland of the 1960s with that of today through archival photos.
Medicine/Pharmacology - Business/Economics
26.03.2017
Computer Science/Telecom - Philosophy
25.03.2017
What morals do intelligent machines have and need?
What morals do intelligent machines have and need?
Sometimes it's the questions, rather than the answers, that show how the world is changing. For example, questions about the moral consequences of machines and computers becoming more intelligent.
Careers/Employment - Physics/Materials Science
24.03.2017
Facilitating innovation in space
Facilitating innovation in space
The ESA BIC Switzerland  programme is starting its second round with seven additional start-ups. Amongst others, the jury was won over by the ETH spin-off ‘IRsweep'. Using a spectrometer that utilises infra-red laser radiation, the startup wants to make environmental analysis from space more precise.
Medicine/Pharmacology
23.03.2017
Alcon receives US FDA approval for new AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction
Alcon receives US FDA approval for new AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction The unique optical de
Event - Architecture
23.03.2017
Medicine/Pharmacology
22.03.2017
Novartis provides update on Phase III study of RLX030 (serelaxin) in patients with acute heart failure
Phase III RELAX-AHF-2 study did not meet primary endpoints of reduced cardiovascular death or worsening heart failure in patients with acute heart failure   Novartis remains committed to improving and extending the lives of patients with cardiovascular disease and will continue to invest in ways to improve their outcomes Basel, March 22, 2017 - Novartis today announced results from the global Phase III RELAX-AHF-2 study investigating the efficacy, safety and tolerability of RLX030 (serelaxin) in patients with acute heart failure (AHF).
Chemistry - Physics/Materials Science
22.03.2017
Rare Earths Become Water-repellent Only as They Age
Rare Earths Become Water-repellent Only as They Age
Surfaces that have been coated with rare earth oxides develop water-repelling properties only after contact with air. Even at room temperature, chemical reactions begin with hydrocarbons in the air. In the journal Scientific Reports, researchers from the University of Basel, the Swiss Nanoscience Institute and the Paul Scherrer Institute report that it is these reactions that are responsible for the hydrophobic effect.
Physics/Materials Science
21.03.2017
Start with the users
Start with the users
An app for building managers - or data glasses that help you learn physics concepts' During the first "SPH Innovation Challenge", ETH students spent a week working on their own project ideas.
Medicine/Pharmacology - Administration/Government
21.03.2017
Novartis’ Cosentyx is first and only IL-17A inhibitor to potentially modify the course of psoriasis
New data suggests that disease modification with Cosentyx may be achievable for around 20% of patients following one year of treatment   Patients with longer disease duration before treatment with Co
Environment/Sustainable Development - Life Sciences
20.03.2017
ACE completes its voyage around Antarctica
The Antarctic Circumnavigation Expedition (ACE) reached Cape Town on Sunday, 19 March, completing its three-month voyage around the great white continent. But the scientific adventure has only just begun: it's now time to analyze all the data that was collected. This will improve our understanding of the effects of global warming on the Southern Ocean and the broader implications for our planet as a whole.
Sport Sciences
20.03.2017
The new NEST unit is slowly taking shape
The new NEST unit is slowly taking shape
The building work on the new Solar Fitness & Wellness unit is making steady progress. From August onwards, users will be able to enthusiastically indulge their sporting passions and then afterwards no less enthusiastically relax and recover from their efforts.
Medicine/Pharmacology - Administration/Government
18.03.2017
New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26% vs.
Life Sciences - Medicine/Pharmacology
17.03.2017
Cut the long story short - and stitch it back together
Cut the long story short - and stitch it back together
Media releases, information for representatives of the media Media Relations (E) A species of unicellular ciliate has found a special trick to make use of the cellular machinery in seemingly impossible ways.
Physics/Materials Science - Chemistry
17.03.2017
Hydrogen inclusions mapped in high-resolution and in 3D
Hydrogen inclusions mapped in high-resolution and in 3D
Using a nano-tomography method, material scientists have succeeded in localizing hydrogen inclusions within a structural metal in 3D for the first time. This was made possible by a uniquely modified measurement method developed at ETH Zurich. Hydrogen is a problem for many metals. If hydrogen atoms are included in a metal, the material properties can be severely affected, causing it to become brittle or cracked.
Earth Sciences - Chemistry
16.03.2017
The dream of building bridges
The dream of building bridges
The French geologist Matthieu Galvez is one of the winners of the Branco Weiss Fellowship 2016. We discuss how he will be using this fellowship, how it will benefit him and why he chose a career as a researcher.
Event - Administration/Government
16.03.2017
Computer Science/Telecom - Physics/Materials Science
16.03.2017
3-D X-ray imaging makes the finest details of a computer chip visible
3-D X-ray imaging makes the finest details of a computer chip visible
Researchers of the Paul Scherrer Institute PSI have made detailed 3-D images of a commercially available computer chip. This marks the first time a non-destructive method has visualized the paths of a chip's internal wiring (just 45 nanometres — 45 millionths of a millimetre — wide) and its 34-nanometre-high transistors clearly without distortions or deformations.
Medicine/Pharmacology - Computer Science/Telecom
14.03.2017
Is Reliable Artificial Intelligence Possible?
Is Reliable Artificial Intelligence Possible?
In the quest for reliable artificial intelligence, EPFL scientist Marcel Salathé argues that AI technology should be openly available.
Environment/Sustainable Development - Physics/Materials Science
14.03.2017
Life Sciences - Environment/Sustainable Development
14.03.2017
Spiders Eat 400-800 Million Tons of Prey Every Year
Spiders Eat 400-800 Million Tons of Prey Every Year
It has long been suspected that spiders are one of the most important groups of predators of insects.
Medicine/Pharmacology - Physics/Materials Science
14.03.2017
Rays of hope for patients
Rays of hope for patients
Tumours of the eye are rare. Yet for those affected, they mean a stroke of fate that involves not only the loss of vision but often the whole eye as well.
Medicine/Pharmacology
13.03.2017
Sandoz announces winners of inaugural Healthcare Access Challenge (Sandoz HACk)
Three winners, chosen by expert panel at Wired Health 2017 in London, identified innovative approaches to address access challenges in Ghana, the Maldives and the Philippines.
Medicine/Pharmacology - Life Sciences
13.03.2017
Novartis Kisqali (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor
Novartis Kisqali (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor Approved based on a first-line P
Medicine/Pharmacology - Life Sciences
13.03.2017
Joint Efforts Towards Treating Paralysis
EPFL scientists Stéphanie Lacour and Grégoire Courtine report on the status of their research and share their vision about the future of wearable neuroprosthetics at this year's edition of South by South West in Austin, Texas, on March 12 th .
Life Sciences - Physics/Materials Science
10.03.2017
New professors appointed
New professors appointed
The ETH Board appointed three new professors and awarded the title of Professor to five recipients upon application of ETH President Lino Guzzella At its meeting of 8/9 March 2017, the ETH Board appo
Microtechnics/Electroengineering - Physics/Materials Science
10.03.2017
Nominations of EPFL professors
Nominations of EPFL professors
The Board of the Swiss Federal Institutes of Technology has announced the appointment of five professors at EPFL.
Microtechnics/Electroengineering - Environment/Sustainable Development
10.03.2017
Medicine/Pharmacology
09.03.2017
People who Trust Their Doctor Tend to Feel Better
Confidence in doctors, therapists and nursing staff leads to an improvement in subjectively perceived complaints, satisfaction and quality of life in patients. This is the conclusion of a meta-analysis by psychologists at the University of Basel, published in the journal PLOS ONE. Trust in doctors, therapists and nursing staff is a key requirement when treating patients, and is already laid down as a principle in the ethical guidelines and professional codes of each clinical field.
Computer Science/Telecom
08.03.2017
An insight into the workplace of tomorrow
An insight into the workplace of tomorrow
Could we soon be working alongside robots' Treffpunkt Science City will focus on this and other questions at the Experience Sundays dedicated to "Working in the World 4.0".
Architecture - Environment/Sustainable Development
07.03.2017
Building a nomadic pavilion out of old skis
Building a nomadic pavilion out of old skis
Could recovered materials play a key role in tomorrow‘s civil engineering' EPFL researchers set out to answer that question by creating an easily demountable pavilion out of more than 200 reclaimed skis.
Architecture - Environment/Sustainable Development
07.03.2017
Building a nomad pavilion out of old skis
Building a nomad pavilion out of old skis
Could recovered materials play a key role in tomorrow‘s civil engineering' EPFL researchers set out to answer that question by creating an easily demountable pavilion out of more than 200 reclaimed skis.
Physics/Materials Science
06.03.2017
Up-and-coming scientists compete at EPFL
Up-and-coming scientists compete at EPFL
On Saturday, EPFL hosted 250 budding young scientists - aged between 8 and 15 - in the fifth annual ‘Curious and Inventive' science competition, run by the school's Science Outreach Department.
Medicine/Pharmacology - Life Sciences
06.03.2017
New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine
Sandoz proposed biosimilar adalimumab (GP2017) shown to have equivalent efficacy and a similar safety profile as reference medicine, Humira * Comprehensive development program show potential of GP2017 to treat inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis Study reinforces strength of Sandoz pipeline and its key role in the broader Novartis immunology portfolio Holzkirchen, 6 March 2017 - Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today presented data for its proposed biosimilar adalimumab (GP2017).
Medicine/Pharmacology
06.03.2017
Novartis’ Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
New analysis shows 94% of patients on Cosentyx regained PASI 75, with up to 80% of patients regaining PASI 90 to 100 after only 16 weeks of retreatment   Cosentyx has shown superior and sustained results versus both Stelara and Enbrel, delivering long-lasting clear or almost clear skin (PASI 90 to 100) ,   Cosentyx has treated 80,000 patients worldwide to date and is the only IL-17A inhibitor approved in psoriasis, psoriatic arthritis and ankylo
Literature/Linguistics
05.03.2017
Mathematics - Event
03.03.2017
Mathematics as key competency
Mathematics as key competency
Data collection and analysis is becoming increasingly important in today's world. This is particularly true for the economic and societal development of poorer nations.
Business/Economics - Environment/Sustainable Development
03.03.2017
Environmental aspects in financial market policy: Federal Council is informed of progress made
Bern, 03.03.2017 - Sustainability is important also for the financial markets.
Physics/Materials Science - Astronomy
02.03.2017
New
New "heart" for CERN’s CMS experiment
CERN's CMS experiment - one of the detectors at the Large Hadron Collider received a new heart today - a pixel detector much like a high-speed digital camera that snaps images up to 40 million times per second. Earlier today, physicists and engineers at CERN replaced the heart of the Compact Muon Solenoid ( CMS ) experiment, one of the two general purpose particle physics detectors that discovered the Higgs boson in 2012.
Physics/Materials Science - Chemistry
02.03.2017
X-ray pulses make atomic oscillations
X-ray pulses make atomic oscillations
Researchers from the Max Born Institute in Berlin, Empa and the US National Institute of Standards and Technology (NIST) have, for the first time, been able to observe minute, ultrafast atomic oscillations in a crystal lattice with the help of a new experimental technique. These oscillations, which are triggered by light pulses, are based on a physical effect - Raman scattering - which was postulated about 100 years ago.

 
 
Logo Careerjet